What Do We Know about Capital Structure? Some Evidence from International Data

Superior Capsule Reconstruction: What Do We Know?

The management of irreparable rotator cuff tears remains challenging. Since its introduction by Mihata in 2012, superiorcapsule reconstruction (SCR) has grown in popularity at an astonishingly rapid rate. The aim of this article is to providea comprehensive review of the available literature, in order to highlight what has so far been published on SCR,covering all aspects including biomechanica...

Do We Know What We Do not Know? A Response to Celine Bonnet

Molecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.

Invasive aspergillosis (IA) are a major complication in immunocompromized patients where can be serious and rapidly fatal. Early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. But despite many efforts to develop detection methods, the diagnosis of IA still remains challenging and current conventional methods are limited for adequate diagno...

Uncertainty, Investment and Capital Accumulation: What Do We Know and What Do We Not Know

In the past four decades there has been considerable interest in the e¤ects that uncertainty has on a …rm’s investment decision and the resulted capital accumulation. This chapter surveys consensus, controversies and open questions in the literature under a general dynamic programming framework. We illustrate that the key answers to the e¤ects of uncertainty depend on the forms of adjustment co...

Fungal Melanin: What do We Know About Structure?

The production of melanin significantly enhances the virulence of many important human pathogenic fungi. Despite fungal melanin's importance in human disease, as well as melanin's contribution to the ability of fungi to survive in diverse hostile environments, the structure of melanin remains unsolved. Nevertheless, ongoing research efforts have progressively revealed several notable structural...